What is Zacks Research's Estimate for MD FY2025 Earnings?

Key Points

• Zacks Research has raised its FY2025 earnings per share estimate for Pediatrix Medical Group to $1.63, slightly up from the previous estimate of $1.62.
• The company reported a quarterly earnings of $0.53 EPS, exceeding the consensus estimate of $0.42, with revenue at $468.84 million.
• Pediatrix Medical Group's stock currently has a consensus price target of $16.79 and a "Hold" rating from Zacks Research.

Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) - Zacks Research increased their FY2025 earnings per share estimates for shares of Pediatrix Medical Group in a report issued on Wednesday, October 8th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.63 per share for the year, up from their previous forecast of $1.62. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Pediatrix Medical Group's current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group's Q1 2026 earnings at $0.24 EPS.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company's quarterly revenue was down 7.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.34 EPS.

A number of other analysts also recently commented on the company. Weiss Ratings restated a "hold (c)" rating on shares of Pediatrix Medical Group in a report on Wednesday. UBS Group upped their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Wall Street Zen raised shares of Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a research report on Saturday, October 4th. Finally, Leerink Partners lifted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research note on Friday, September 5th. Two equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $16.79.

Pediatrix Medical Group Price Performance

MD stock opened at $16.22 on Friday. Pediatrix Medical Group has a 1 year low of $11.59 and a 1 year high of $18.22. The firm has a market cap of $1.41 billion, a P/E ratio of 12.57 and a beta of 1.26. The stock's 50 day moving average price is $16.19 and its 200 day moving average price is $14.49. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. AlphaQuest LLC grew its holdings in shares of Pediatrix Medical Group by 16.0% in the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in shares of Pediatrix Medical Group by 8.7% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company's stock valued at $171,000 after purchasing an additional 950 shares during the period. SummerHaven Investment Management LLC boosted its stake in shares of Pediatrix Medical Group by 0.9% during the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after purchasing an additional 1,028 shares during the period. New York State Common Retirement Fund raised its holdings in shares of Pediatrix Medical Group by 1.7% in the second quarter. New York State Common Retirement Fund now owns 62,245 shares of the company's stock valued at $893,000 after acquiring an additional 1,034 shares in the last quarter. Finally, EP Wealth Advisors LLC raised its holdings in shares of Pediatrix Medical Group by 5.5% in the second quarter. EP Wealth Advisors LLC now owns 22,579 shares of the company's stock valued at $324,000 after acquiring an additional 1,180 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.